Cost of Pediatric Visceral Leishmaniasis Care in Morocco

dc.contributor.authorTachfouti, Nabil
dc.contributor.authorNajdi, Adil
dc.contributor.authorAlonso, Sergi
dc.contributor.authorSicuri, Elisa
dc.contributor.authorLaamrani El Idrissi, Abderahmane
dc.contributor.authorNejjari, Chakib
dc.contributor.authorPicado de Puig, Albert
dc.date.accessioned2016-07-18T07:58:38Z
dc.date.available2016-07-18T07:58:38Z
dc.date.issued2016-06-03
dc.date.updated2016-06-29T18:00:15Z
dc.description.abstractBACKGROUND: Visceral leishmaniasis (VL) is a neglected parasitic disease that is fatal if left untreated. VL is endemic in Morocco and other countries in North Africa were it mainly affects children from rural areas. In Morocco, the direct observation of Leishmania parasites in bone marrow aspirates and serological tests are used to diagnose VL. Glucantime is the first line of treatment. The objective of this study was to report the costs associated to standard clinical management of pediatric VL from the provider perspective in Morocco. As a secondary objective we described the current clinical practices and the epidemiological characteristics of pediatric VL patients. METHODS: From March to June 2014 we conducted a survey in eight hospitals treating pediatric VL patients in Morocco. A pro-forma was used to collect demographic, clinical and management data from medical records. We specifically collected data on VL diagnosis and treatment. We also estimated the days of hospitalization and the time to start VL treatment. Costs were estimated by multiplying the use of resources in terms of number of days in hospital, tests performed and drugs provided by the official prices. For patients receiving part of their treatment at Primary Health Centers (PHC) we estimated the cost of administering the Glucantime as outpatient. We calculated the median cost per VL patient. We also estimated the cost of managing a VL case when different treatment strategies were applied: inpatient and outpatient. RESULTS: We obtained data from 127 VL patients. The median total cost per pediatric VL case in Morocco is 520 US$. The cost in hospitals applying an outpatient strategy is significantly lower (307 US$) than hospitals keeping the patients for the whole treatment (636 US$). However the outpatient strategy is not yet recommended as VL treatment for children in the Moroccan guidelines. VL diagnosis and treatment regimens should be standardized following the current guidelines in Morocco.
dc.format.extent13 p.
dc.format.mimetypeapplication/pdf
dc.identifier.issn1932-6203
dc.identifier.pmid27257808
dc.identifier.urihttps://hdl.handle.net/2445/100561
dc.language.isoeng
dc.publisherPublic Library of Science (PLoS)
dc.relation.isformatofReproducció del document publicat a: http://dx.doi.org/10.1371/journal.pone.0155482
dc.relation.ispartofPLoS One, 2016, vol. 11, num. 6, p. e0155482
dc.relation.urihttp://dx.doi.org/10.1371/journal.pone.0155482
dc.rightscc by (c) Tachfouti et al., 2016
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/
dc.sourceArticles publicats en revistes (ISGlobal)
dc.subject.classificationLeishmaniosi
dc.subject.classificationInfants
dc.subject.classificationMarroc
dc.subject.otherLeishmaniasis
dc.subject.otherChildren
dc.subject.otherMorocco
dc.titleCost of Pediatric Visceral Leishmaniasis Care in Morocco
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
tachfouti2016_2152.pdf
Mida:
319.54 KB
Format:
Adobe Portable Document Format